Who owns ENGENE THERAPEUTICS INC?
- CUSIP Number: 29286x119
Tip: Access positions for across all investors
Analyze quarterly positions in Engene Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Engene Therapeutics stock
Who bought or sold ENGENE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BVF | 945k | $274k | 100% | Jun 2026 |
|
| Blue Owl Capital Holdings | 511k | $148k | 100% | Jun 2026 |
|
| Caption Management | 334k | $97k | 100% | Jun 2026 |
|
| LMR Partners | 310k | $90k | 100% | Jun 2026 |
|
| Aristeia Capital | 198k | $48k | 100% | Jun 2026 |
|
| D. E. Shaw & Co | 105k | $30k | 100% | Jun 2026 |
|
| Millennium Management | 69k | $20k | 100% | Jun 2026 |
|
| Toronto-Dominion Bank | 32k | $9.1k | 100% | Jun 2026 |
|
| CSS | 17k | $4.9k | 100% | Jun 2026 |
|
| Intl Fcstone | 10k | $8.9k | 100% | Jun 2026 |
|
| Clear Street Group | 200.00 | $58.000000 | 100% | Jun 2026 |
|